Schedule 13G ownership disclosure
INOZYME PHARMA INC
Security class unavailable · CUSIP: 45790W108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,491,236
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-24-002134
- Form type
- SC 13G
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 24, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership